Keywords: 17-Hydroxyprogesterone; Brain; Cognition; Congenital adrenal hyperplasia; Congenital hypothyroidism; Diabetic Ketoacidosis; Direcnet; Hypoglycemia; Inflammation; Metabolic syndrome; Neonatal screening; Obesity; Subcutaneous adipose tissue; Type 1 diabetes; Visceral adipose tissue.